United States June 28, 2018 6:35 am

FDA Reviewing Treatment for Aggressive Prostate Cancer

The Federal Drug Administration is reviewing approval of enzalutamide, a drug which lowered the risk of metastasis or death in men with non-metastatic hormone-resistant prostate cancer, according to a new study of 1,400 patients. Ashley Ross MD, oncologist at Baylor Scott & White Medical Center – Plano, discusses the trial.

Wake Up to Something Good

1:57

‘The Wall That Heals' comes to Frisco
1:51

Child killed in Johnson County flooding
0:38

Pet of the Week: Matrix!
2:23

Parents of Fort Worth drive-by shooting victims recalls horrifying moments
2:05

Community raises money for teenage hit-and-run victim
Exit mobile version